B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Psilocybin

The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN.

300 PubMed studies analyzed · 25 RCTs · Evidence Score: 51.9

Research Domains

Psilocybin has been studied across 14 research domains including 🌤️ Mood & Depression, 🧘 Stress & Anxiety, ⏳ Longevity & Aging, 🔬 Oncology, 🧠 Cognitive. The primary research focus is 🌤️ Mood & Depression with 52% of studies addressing this area.

Loading evidence profile...

This evidence profile for Psilocybin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.